Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.
Worldwide Research and Development, Pfizer, Inc., Eastern Point Road, Groton, Connecticut 06340, United States.
J Am Chem Soc. 2022 Apr 13;144(14):6163-6172. doi: 10.1021/jacs.2c01630. Epub 2022 Apr 4.
We report a copper-catalyzed strategy for arylboronic ester synthesis that exploits photoinduced ligand-to-metal charge transfer (LMCT) to convert (hetero)aryl acids into aryl radicals amenable to ambient-temperature borylation. This near-UV process occurs under mild conditions, requires no prefunctionalization of the native acid, and operates broadly across diverse aryl, heteroaryl, and pharmaceutical substrates. We also report a one-pot procedure for decarboxylative cross-coupling that merges catalytic LMCT borylation and palladium-catalyzed Suzuki-Miyaura arylation, vinylation, or alkylation with organobromides to access a range of value-added products. The utility of these protocols is highlighted through the development of a heteroselective double-decarboxylative C(sp)-C(sp) coupling sequence, pairing copper-catalyzed LMCT borylation and halogenation processes of two distinct acids (including pharmaceutical substrates) with subsequent Suzuki-Miyaura cross-coupling.
我们报告了一种铜催化的芳基硼酸酯合成策略,该策略利用光诱导的配体-金属电荷转移(LMCT)将(杂)芳基酸转化为可在环境温度下进行硼化的芳基自由基。该近紫外过程在温和条件下发生,不需要对天然酸进行预官能化,并且在各种芳基、杂芳基和药物底物中广泛适用。我们还报告了一种一锅法脱羧交叉偶联程序,该程序将催化 LMCT 硼化与钯催化的 Suzuki-Miyaura 芳基化、乙烯基化或烷基化与有机溴化物相结合,以获得一系列增值产品。这些方案的实用性通过开发杂选择性双脱羧 C(sp)-C(sp)偶联序列得到了强调,该序列将铜催化的 LMCT 硼化和两个不同酸(包括药物底物)的卤化过程与随后的 Suzuki-Miyaura 交叉偶联配对。